No writing assistance was utilized in the production of this manuscript. The combined use of antiplatelet drugs acting through different mechanisms is important in antithrombotic treatment of ...
Antiplatelet drugs are anticoagulants that work by making platelets less likely to stick to each other in your blood vessels.
The mode of action of aspirin as an antiplatelet agent is through an irreversible ... the Society for Cardiovascular Angiography and Interventions Drug-eluting Task Force published an excellent ...
The fields of pharmacology and dentistry have long been intertwined. Medications prescribed for heart conditions — such as ...
With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...
Singh, A. , Sinha, R. , Saran, M. , Kazmi, D. , Gupta, H. and Seth, G. (2025) Efficacy and Safety of Dual Antiplatelet Therapy in High-Risk, Post-Percutaneous Coronary Intervention Patients beyond One ...
The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...
All of the studies used aspirin as the antiplatelet therapy. The researchers found that apixaban had similar rates of major bleeding and intracranial hemorrhage compared with aspirin (risk ...
Bentracimab is an investigational human monoclonal antibody fragment that binds to ticagrelor, an oral P2Y 12 platelet inhibitor, reversing its antiplatelet effects. The BLA submission is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback